tafamidis
This page covers all tafamidis drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Transthyretin.
Targets
Marketed (3)
- Vyndaqel · Foldrx Pharms · Neuroscience · 1430.0
Vyndaqel works by stabilizing the transthyretin protein to prevent its misfolding and aggregation into amyloid fibrils. - Vyndaqel · Foldrx Pharms · Neuroscience
Vyndaqel stabilizes the Transthyretin protein, preventing its misfolding and aggregation into amyloid fibrils. - Vyndaqel · Foldrx Pharms · Neuroscience
Vyndaqel works by stabilizing the transthyretin protein to prevent its misfolding and aggregation into amyloid fibrils.